Crossmark

Association of the C-reactive protein–triglyceride–glucose index with metabolic dysfunction-associated steatotic liver disease and long-term all-cause and cardiovascular mortality: evidence from two nationwide prospective cohort studies

Crossref DOI link: https://doi.org/10.1186/s12933-026-03119-x

Published Online: 2026-03-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jin, Xue-Feng

Su, Zhao-Jie

Zhong, Jian-Fa

Wang, Jie

Shi, Bao-Jie

Liu, Zhen-Yu

Li, Ping-Sui

Xiong, Xing

Xu, Shi-Quan

Qiu, Cheng

Xiao, Yi

Li, Si-Bo

Tong, Wen-Hui

Ge, Jing-Ping

Li, Hang-Xu

Liu, Xiao-Yan

Li, Zi-Zhi

Kong, Xiang-Rui

Chen, Jun-Lin

Wen, Xue-Jiao

Sun, Pan

Chen, Peng-Peng

Li, Yang-Yang

Chen, Yang

Mao, Lan-Tian

Peng, Zhi-Hai

Li, Hao

Zhang, Tong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82370669, 82201964)
License Information

Text and Data Mining valid from 2026-03-02

Version of Record valid from 2026-03-05
More Information

Article History

Received: 18 December 2025

Accepted: 10 February 2026

First Online: 2 March 2026

Declarations

:

: The National Centre for Health Statistics (NCHS) and the Centres for Disease Control and Prevention (CDC) are responsible for conducting NHANES. Additionally, the NCHS Research Ethics Review Committee examined and approved the NHANES study protocol. Written informed consent was given by each NHANES participant. All participants gave written informed consent, and CHARLS was authorised by Peking University’s Institutional Review Board (approval number: IRB00001052-11015 for the home survey and IRB00001052-11014 for blood samples).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below